These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Formulations and use of androgens in women. Chu MC; Lobo RA Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S3-7. PubMed ID: 15065631 [TBL] [Abstract][Full Text] [Related]
26. Androgens in postmenopausal women: production, possible role, and replacement options. Lobo RA Obstet Gynecol Surv; 2001 Jun; 56(6):361-76. PubMed ID: 11466487 [TBL] [Abstract][Full Text] [Related]
27. Role of androgens in surgical menopause. Gelfand MM Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 2):S325-7. PubMed ID: 10076173 [TBL] [Abstract][Full Text] [Related]
28. Androgen therapy in women: what we think we know. Drillich A; Davis SR Exp Gerontol; 2007 Jun; 42(6):457-62. PubMed ID: 17407803 [TBL] [Abstract][Full Text] [Related]
29. Psychological consequences of surgical menopause. Taylor M J Reprod Med; 2001 Mar; 46(3 Suppl):317-24. PubMed ID: 11304879 [TBL] [Abstract][Full Text] [Related]
30. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women. Simon J; Klaiber E; Wiita B; Bowen A; Yang HM Menopause; 1999; 6(2):138-46. PubMed ID: 10374221 [TBL] [Abstract][Full Text] [Related]
31. [Female sexual dysfunction and postmenopausal androgen therapy]. Delcominette S; Gaspard U Rev Med Liege; 2008 Jan; 63(1):23-30. PubMed ID: 18303682 [TBL] [Abstract][Full Text] [Related]
32. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women. Stephenson K; Neuenschwander PF; Kurdowska AK Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic effects of progestins, androgens, and tibolone for menopausal symptoms. Liu JH Am J Med; 2005 Dec; 118 Suppl 12B():88-92. PubMed ID: 16414332 [TBL] [Abstract][Full Text] [Related]
34. Potential anabolic effects of androgens on bone. Kearns AE; Khosla S Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S14-8. PubMed ID: 15065633 [TBL] [Abstract][Full Text] [Related]
37. Estrogen-androgen for hormone replacement. A review. Rosenberg MJ; King TD; Timmons MC J Reprod Med; 1997 Jul; 42(7):394-404. PubMed ID: 9252929 [TBL] [Abstract][Full Text] [Related]
38. Prognostic features of menopausal and postmenopausal applicants for life insurance. Schiefeling M J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866 [TBL] [Abstract][Full Text] [Related]
39. Androgens in postmenopausal women: a review. Shifren JL; Davis SR Menopause; 2017 Aug; 24(8):970-979. PubMed ID: 28609390 [TBL] [Abstract][Full Text] [Related]
40. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women. Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]